Nature Communications (Oct 2024)

The G4 resolvase Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development

  • Pablo Gómez-del Arco,
  • Joan Isern,
  • Daniel Jimenez-Carretero,
  • Dolores López-Maderuelo,
  • Rebeca Piñeiro-Sabarís,
  • Fadoua El Abdellaoui-Soussi,
  • Carlos Torroja,
  • María Linarejos Vera-Pedrosa,
  • Mercedes Grima-Terrén,
  • Alberto Benguria,
  • Ana Simón-Chica,
  • Antonio Queiro-Palou,
  • Ana Dopazo,
  • Fátima Sánchez-Cabo,
  • José Jalife,
  • José Luis de la Pompa,
  • David Filgueiras-Rama,
  • Pura Muñoz-Cánoves,
  • Juan Miguel Redondo

DOI
https://doi.org/10.1038/s41467-024-52809-1
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Extensive genetic studies have elucidated cardiomyocyte differentiation and associated gene networks using single-cell RNA-seq, yet the intricate transcriptional mechanisms governing cardiac conduction system (CCS) development and working cardiomyocyte differentiation remain largely unexplored. Here we show that mice deleted for Dhx36 (encoding the Dhx36 helicase) in the embryonic or neonatal heart develop overt dilated cardiomyopathy, surface ECG alterations related to cardiac impulse propagation, and (in the embryonic heart) a lack of a ventricular conduction system (VCS). Heart snRNA-seq and snATAC-seq reveal the role of Dhx36 in CCS development and in the differentiation of working cardiomyocytes. Dhx36 deficiency directly influences cardiomyocyte gene networks by disrupting the resolution of promoter G-quadruplexes in key cardiac genes, impacting cardiomyocyte differentiation and CCS morphogenesis, and ultimately leading to dilated cardiomyopathy and atrioventricular block. These findings further identify crucial genes and pathways that regulate the development and function of the VCS/Purkinje fiber (PF) network.